Sunday 14 June I bought into PXS on Friday and yesterday published a brief note to highlight the transaction, including the latest chart. Today’s update is intended to give you a flavour of the fundamentals. Pharmaxis Ltd (PXS, price 23.5¢, mkt cap $74m) is a junior pharmaceutical company with a focus on products for chronic … Read more
To access this post, you must purchase a membership.